montage illustration about dna research containing gene therapy, test tubes, and a persons silhouette - 基因療法 幅插畫檔、美工圖案、卡通及圖標
montage illustration about genetic engineering containing chromosomes, dna, chemicals, a sheep, and cloning - 基因療法 幅插畫檔、美工圖案、卡通及圖標
Illustration of the CAR-T cell membrane receptor, a T lymphocyte genetically modified for immunotherapy cancer treatment. The receptor bonds the...細胞
Illustration of the principle of CAR-T cell immunotherapy consisting of modifying some of the patients immune cells, T lymphocytes, so that they...插圖, 輔導, 癌症
Illustration of the CAR-T cell membrane receptor, a T lymphocyte genetically modified for immunotherapy cancer treatment. The receptor bonds the...癌症
Chairman William H. Frist, R-tenn., listens to Paul Gelsinger, father of young man killed in gene therapy trial, testifie before the Senate Public...
Paul Gelsinger, father of young man killed in gene therapy trial, testifies before the Senate Public Health subcomittee hearing on safety concerns...
James Watson, co-discoverer of the DNA helix attends a press conference on the completion of the first assembly of the human genome June 26, 2000 in...
Dr. Eric Lander, Director of the Whitehead Institute/MIT Center for Genome Research speaks during a press conference on the completion of the first...
Dr. Eric Lander, Director of the Whitehead Institute/MIT Center for Genome Research speaks during a press conference on the completion of the first...
Richard Gibbs of Baylor College of Medicine attends a press conference on the completion of the first assembly of the human genome June 26, 2000 in...
Robert H. Waterston of Washington University School of Medicine in St. Louis smiles during a press conference on the completion of the first assembly...
Elbert Branscomb of the Lawrence Livermore National Laboratory attends a press conference on the completion of the first assembly of the human genome...
Samuel Broder, Executive Vice President and Chief Medical Officer of Celera Genomics Inc. Attends a press conference on the completion of the first...
Marshall Peterson, Senior Director of Infrastructure Technology of Celera Genomics Inc. Smiles during a press conference on the completion of the...
Francis Collins, Director of the National Human Genome Research Institute, NIH speaks during a press conference on the completion of the first...
Hamilton O. Smith, Senior Director of DNA Resources of Celera Genomics Inc. Attends a press conference on the completion of the first assembly of the...
Eugene W. Myers, Vice President of Informatics Research of Celera Genomics Inc. Attends a press conference on the completion of the first assembly of...
Mark D. Adams, Vice President of Genome Programs of Celera Genomics Inc. Attends a press conference on the completion of the first assembly of the...
Francis Collins, Director of the National Human Genome Research Institute, NIH adjust his glasses during a press conference on the completion of the...
Craig Venter, President and Chief Scientific Officer of Celera Genomics Inc. Speaks during a press conference on the completion of the first assembly...
Craig Venter, left, President and Chief Scientific Officer of Celera Genomics Inc. Speaks as Francis Collins, right, Director of the National Human...
Craig Venter, left, President and Chief Scientific Officer of Celera Genomics Inc. Speaks as Francis Collins, right, Director of the National Human...
Muscle bound, gene altered mouse at the University of Pennsylvania School of Medicine. Elisabeth Barton, Assistant Professor, Anatomy and Cell...基因改造
Muscle bound, gene altered mouse at the University of Pennsylvania School of Medicine. Elisabeth Barton, Assistant Professor, Anatomy and Cell...改變, 基因改造
Technician works at the Neuromuscular Diseases and Gene Therapy Team Laboratory on October 13, 2026 in Evry, France. AFM-Téléthon Association...
Technician works at the Neuromuscular Diseases and Gene Therapy Team Laboratory on October 13, 2026 in Evry, France. AFM-Téléthon Association...
Technician works at the Neuromuscular Diseases and Gene Therapy Team Laboratory on October 13, 2026 in Evry, France. AFM-Téléthon Association...
Technician works at the Neuromuscular Diseases and Gene Therapy Team Laboratory on October 13, 2026 in Evry, France. AFM-Téléthon Association...
Technician works at the Neuromuscular Diseases and Gene Therapy Team Laboratory on October 13, 2026 in Evry, France. AFM-Téléthon Association...
Technician works at the Neuromuscular Diseases and Gene Therapy Team Laboratory on October 13, 2026 in Evry, France. AFM-Téléthon Association...
Technician works at the Neuromuscular Diseases and Gene Therapy Team Laboratory on October 13, 2026 in Evry, France. AFM-Téléthon Association...